These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32586404)

  • 1. Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells.
    Wang L; Zi H; Luo Y; Liu T; Zheng H; Xie C; Wang X; Huang X
    Stem Cell Res Ther; 2020 Jun; 11(1):258. PubMed ID: 32586404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer.
    Cui D; Dai J; Keller JM; Mizokami A; Xia S; Keller ET
    Clin Cancer Res; 2015 Oct; 21(20):4619-29. PubMed ID: 26202948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
    Yan J; Tang D
    Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.
    Ye QF; Zhang YC; Peng XQ; Long Z; Ming YZ; He LY
    Asian Pac J Cancer Prev; 2012; 13(6):2485-9. PubMed ID: 22938409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
    Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K
    Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin Antagonizes Prostate Cancer Stemness via Inhibiting Notch1/NF-κB Signaling Pathway.
    Wu MH; Wu K; Zhu YB; Li DC; Yang H; Zeng H
    Chin J Integr Med; 2023 Oct; 29(10):914-923. PubMed ID: 37357241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells.
    Wang L; Ning J; Wakimoto H; Wu S; Wu CL; Humphrey MR; Rabkin SD; Martuza RL
    Mol Ther Oncolytics; 2019 Jun; 13():58-66. PubMed ID: 31016228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
    Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition.
    Qiu S; Deng L; Bao Y; Jin K; Tu X; Li J; Liao X; Liu Z; Yang L; Wei Q
    Anticancer Drugs; 2018 Oct; 29(9):871-879. PubMed ID: 29944470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic characterization of sphere-derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance.
    Luo Y; Yu J; Lin Z; Wang X; Zhao J; Liu X; Qin W; Xu G
    Int J Cancer; 2024 Aug; 155(4):742-755. PubMed ID: 38647131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Midkine Suppresses Prostate Cancer CD133
    Erdogan S; Doganlar ZB; Doganlar O; Turkekul K; Serttas R
    Am J Med Sci; 2017 Sep; 354(3):299-309. PubMed ID: 28918838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
    Ahmed AA; Robinson T; Palande M; Escara-Wilke J; Dai J; Keller ET
    J Cell Biochem; 2019 Oct; 120(10):16946-16955. PubMed ID: 31099068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells.
    Gao W; Wang Y; Yu S; Wang Z; Ma T; Chan AM; Chiu PK; Ng CF; Wu D; Chan FL
    Stem Cell Res Ther; 2022 May; 13(1):188. PubMed ID: 35526071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
    Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
    Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells.
    Liu C; Li Z; Bi L; Li K; Zhou B; Xu C; Huang J; Xu K
    Mol Cell Biochem; 2014 Aug; 393(1-2):265-70. PubMed ID: 24782036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
    Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
    Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
    Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
    Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.